KeyBank National Association’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100,000	Closed	-$161K	–	1082
2022 Q1	$161K	Hold	100,000	–	–	﹤0.01%	1043
2021 Q4	$207K	Hold	100,000	–	–	﹤0.01%	1042
2021 Q3	$388K	Buy	+100,000	New	+$388K	﹤0.01%	866